The Ibex extends the falls amid Brexit tension and threatens the 8,100

The bad news of the last session is that the index closed below the minimum of the last four days, which could suggest an attack on the support of 8,000 points, experts from Bolsamanía warn. "Even if it lost this price level, its technical perspectives would not be complicated. The key support is at 7,835 points, prices still very far away," explains César Nuez, analyst at Bolsamanía and head of Trader Watch.

With the European budget hurdle overcome, after the leaders have been able to reach an agreement with Hungary and Poland, the focus is absolutely on Brexit, especially after Boris Johnson, British Prime Minister, warned of the possibility yesterday of leaving the Union without any agreement since the negotiations are not being favorable. We recall that the deadline for reaching a pact was extended until Sunday.

Bank of England Governor Andrew Bailey, who is scheduled to speak this Friday when the central bank releases its financial stability report, has already stated that a no-deal exit would cause more damage to the UK economy than the coronavirus pandemic, a message that he will probably repeat.

Attention is also focused on the banks given the possibility that the European Central Bank (ECB) extends the veto on the payment of the dividend, something that caused them to fall in the past day. The Bank of England, for its part, appears to be lifting the temporary ban on payment to shareholders, but has indicated that dividends distributed for all of 2020 should be capped.

European futures come with cuts of 0.2% on average after Wall Street ended yesterday with a mixed sign and moderate movements. In Asia there has also been a session of diverse movements this morning. Notably, weekly jobless claims figures released yesterday in the US showed a "surprising" rise to 853,000, experts say, well above expectations of 725,000. "This increases the prospects that the US economy will begin to see an acceleration of economic weakness, as the lack of a new stimulus agreement begins to act as an anchor around the ankle of the economic recovery since April. Meanwhile, the Coronavirus cases in the United States have continued to rise, "experts from CMC Marktes highlight.

For the rest, the US FDA is about to approve the Pfizer and BioNTech vaccine after the meeting held last day, in which the expert committee analyzed in depth the results of the investigation presented by the two companies.

In today's calendar, pay attention to the Spanish CPI for November. In the US, the consumer index from the University of Michigan for December will be released.